WHO IVD PQ and EUL Ukraine Workshop
In partnership with the European Regional Office and WHO Country Office in Ukraine the PQ IVD Assessment Team held a virtual Workshop on the 10th of February with regulators from the National Regul
In partnership with the European Regional Office and WHO Country Office in Ukraine the PQ IVD Assessment Team held a virtual Workshop on the 10th of February with regulators from the National Regul
New Invitation for Expression of Interest (EOI) to manufacturers of Antimalarial Medicines.
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
As of 2023 the WHO Prequalification Team has started using the ePQS platform (Salesforce cloud-based software) to manage application submissions and workflow.
We have been receiving applications from several manufacturers of malaria RDTs, either as new product applications or as Change Requests, regarding the inclusion single-test configurations in their
The recent ICH Harmonised Guideline M10 Bioanalytical Method Validation and Study Sample Analysis, adopted by ICH 24 May 2022, will be implemented by PQT/MED effective 1 May 2023
Flucytosine (WHOAPI-406) manufactured by Solara Active Pharma Sciences Limited, has been prequalified by the
The purpose of this Request for Proposals (RFP) is to enter into a contractual agreement with a successful bidder and select a suitable contractor to carry out the maintenance and support of the ev
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Team – Medicines (PQT/MED) updated the variation application form and FAQ variation document:
The 2022 Joint UNICEF-UNFPA-WHO Meeting with Manufacturers and Suppliers took place from 28 November to 1 December 2022 at UN City, Marmorvej 51, 2100 Copenhagen,
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Aabcavir (sulfate) (WHOAPI-377) manufactured by Jiangsu Weiqida Pharmaceutical Co Ltd, has been prequalified by the WHO Prequalific